| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |